SS Innovations International (SSII) Net Income towards Common Stockholders Growth (1y) (2017 - 2026)
Powered by 
Analysis
SS Innovations International (SSII) Net Income towards Common Stockholders Growth (1y) (2017 - 2026) Analysis & Trends
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Net Income Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 187.42 Bn | 182.47 Bn | 7.27 Bn | -47.84% |
| 2 | Intuitive Surgical | 129.78 Bn | 124.69 Bn | 1.96 Bn | 23.94% |
| 3 | Medtronic | 120.53 Bn | 112.33 Bn | 6.34 Bn | 41.36% |
| 4 | Stryker | 116.28 Bn | 112.80 Bn | 4.50 Bn | 44.34% |
| 5 | Boston Scientific | 69.29 Bn | 68.99 Bn | 3.85 Bn | 13.80% |
| 6 | Edwards Lifesciences | 51.83 Bn | 47.68 Bn | 1.35 Bn | -27.18% |
| 7 | Alcon | 34.36 Bn | 32.91 Bn | 1.68 Bn | - |
| 8 | Dexcom | 33.17 Bn | 31.23 Bn | 830.00 Mn | 38.54% |
| 9 | Steris | 21.90 Bn | 21.43 Bn | 684.20 Mn | 12.92% |
| 10 | SS Innovations International | 682.58 Mn | 660.28 Mn | 7.10 Mn | -936.79% |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | -936.79% |
| Mar 31, 2026 | 20.18% |
| Dec 31, 2025 | -253.47% |
| Sep 30, 2025 | 39.24% |
| Jun 30, 2025 | 91.24% |
| Mar 31, 2025 | -60.38% |
| Dec 31, 2024 | 91.00% |
| Sep 30, 2024 | -400.63% |
| Jun 30, 2024 | -58.44% |
| Mar 31, 2024 | 6.48% |
| Dec 31, 2023 | -1,978.23% |
| Sep 30, 2023 | -218.12% |
| Jun 30, 2023 | -368.25% |
| Mar 31, 2023 | -3,620.87% |
| Dec 31, 2022 | -129.63% |
| Sep 30, 2022 | 8.12% |
| Jun 30, 2022 | 4.16% |
| Mar 31, 2022 | 73.20% |
| Dec 31, 2021 | -59.46% |
| Sep 30, 2021 | -11.37% |